Skip to main content

Table 6 Univariate and multivariate regression analysis for risk factors of major complication

From: The impact of sarcopenia and myosteatosis on postoperative outcomes in patients with inflammatory bowel disease

  Univariate analysis Multivariate analysis
OR 95% CI p-value OR 95% CI p-value
Age > 65 years 6.444 1.274–32.593 0.020 4.274 0.242–75.356 0.321
Gender (male) 0.420 0.122–1.449 0.170    
Diagnosis
 Ulcerative colitis 1      
 Crohn 3.167 0.648–15.474 0.154    
 Indeterminate colitis 3.167 0.215–46.726 0.401    
BMI category
 Underweight 1   0.631    
 Normal 0.435 0.063–3.021 0.400    
 Overweight 0.375 0.035–3.999 0.417    
 Obese 0.214 0.021–2.187 0.194    
ASA physical score ≥ 3 2.318 0.660–8.138 0.189    
Charlson Comorbidity index ≥ 3 4.167 1.078–16.103 0.039 1.663 0.141–19.573 0.686
Smoking status
 Non-smoker 1   0.228    
 Ex-smoker 0.684 0.131–3.578 0.653    
 Smoker 2.778 0.734–10.513 0.132    
NLR category > 5 4.320 1.249–14.498 0.021 4.489 1.222–16.494 0.024
Albumin > 35 g/L 0.525 0.169–1.629 0.265    
Preoperative steroid use 1.510 0.488–4.676 0.474    
Preoperative immunosuppression 0.502 0.156–1.617 0.248    
Emergency surgery 2.382 0.690–8.226 0.170    
Sarcopenia 0.925 0.297–2.878 0.893    
Myosteatosis 1.719 0.557–5.304 0.346    
  1. ASA American Society of Anesthesiologists, BMI Body Mass Index, CI confidence interval, NLR neutrophil-lymphocyte ratio, OR odds ratio